We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 05, 2021

Long-Term Real-Life Efficacy and Safety of Apremilast for Psoriasis

Clinical and Experimental Dermatology


Additional Info

Clinical and Experimental Dermatology
Is Apremilast for Psoriasis as Effective and Safe as Reported in Clinical Trials? Five-Year Experience From a Greek Tertiary Hospital: Long-term Real-life Efficacy and Safety of Apremilast in Greece
Clin Exp Dermatol 2021 Apr 02;[EPub Ahead of Print], E Sotiriou, A Tsentemeidou, E Vakirlis, N Sideris, K Bakirtzi, I Papadimitriou, A Lallas, D Ioannides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading